JPMorgan Chase & Co Downgrades Atea Pharmaceuticals (NASDAQ:AVIR) to Underweight theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Atea Pharmaceuticals, Inc (NASDAQ:AVIR) Short Interest Up 9 6% in July theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Rating) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 1,900,000 shares, a growth of 5.6% from the February 28th total of 1,800,000 shares. Based on an average daily trading volume, of 515,100 shares, the days-to-cover ratio […]
Atea Pharmaceuticals (NASDAQ:AVIR – Get Rating) had its price target reduced by equities research analysts at JPMorgan Chase & Co. from $12.00 to $8.00 in a report issued on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 112.20% from […]
SG Americas Securities LLC Purchases Shares of 37,684 Atea Pharmaceuticals, Inc (NASDAQ:AVIR) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.